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RESUMEN
Objetivo: Evaluar la actividad del extracto metanólico de la corteza del tallo de la Bauhinia Racemosa 
Lam  en ratones albinos suizos.
Material y métodos: La inmunidad humoral específica fue evaluada mediante el ensayo de 
hemaglutinación de antincuerpos ( H.A. Titer) y la inmunidad no específica fue evaluada mediante 
el test de aclaramiento de carbono y el test de adhesión de neutrofilos.
Resultados: se encontró que el extracto del tallo de Bauhinia racemosa (MEBR) era efectivo para el 
incremento del H.A Titer. La respuesta primaria y secundaria no mostró un ascenso significativo en 
el H.A Titer en el grupo con estado inmune normal al compararlo con el grupo control. Sin embargo, 
en el grupo de inmunodeprimidos donde la inmunidad estaba suprimida mediante ciclofosfamida 
se observó un aumento significativo en  el H.A Titer (p<0.01)  a dosis de 200mg/kg cuando se 
comparaba con la ciclofosfamida. El extracto del tallo de Bauhinia racemosa mostró un aumento 
significativo (p<0,05) en la actividad fagocítica a dosis de 200mg/kg (p.o) en el test de aclaramiento 
de carbón. En el test de adhesión de neutrófilos el extracto del tallo de Bauhinia racemosa mostró 
un aumento significativo (p<0,01)   del porcentaje de adhesión de neutrófilos a dosis de   200mg/
kg (p.o)
Conclusión: El presente estudio sostiene al MEBR como un prometedor agente inmunomodulador.
PALABRAS CLAVE: Bahunia Racemosa, adhesión inmunomoduladora, neutrófilos, fagocitosis.
ABSTRACT 
Aim: To evaluate immunomodulatory activity of methanolic extract of stem bark of Bauhinia racemosa 
Lam swiss albino mice. 
Material and Methods: The specific humoral immunity was assessed by performing hemagglutinating 
antibody titer (H.A.Titer) and the non-specific immunity was assessed by performing carbon 
clearance test and neutrophil adhesion test. 
Results: The methanolic extract of stem bark of Bauhinia Racemosa (MEBR) was found effective in 
increasing the H.A.Titer. Primary and secondary antibody response showed no significant rise 
in H.A.Titer in normal immune status group when compared with control group, whereas in 
immunosupressed group, where immunity was suppressed by cyclophosphamide, significant 
rise in H.A.Titer (p<0.01) was observed at dose of 200 mg/kg (p.o.) when compared with 
cyclophosphamide. MEBR showed significant increase (p<0.05) in phagocytic activity at dose of 200 
mg/kg (p.o.) in carbon clearance test. In neutrophil adhesion test MEBR showed significant (p<0.01) 
rise in percentage neutrophil adhesion at dose of 200 mg/kg (p.o.). 
Conclusion: Present study, therefore, reveals that MEBR) holds promise as immunomodulatory 
agent. 
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2INTRODUCTION
Herbal medicines derived from plants are being increasingly 
utilized to treat a wide variety of diseases. There is a growing 
interest in the pharmacological evaluation of various plants 
used in Indian traditional system of medicine. The plant 
Bauhinia Racemosa Lam. belongs to the Caesalpiniaceae 
family. It is popularly known as Apta (Marathi) and occurs 
frequently in India, Srilanka and China. The stem bark 
of the plant is an astringent and is used in the treatment 
of headache, fever, skin diseases, tumors, diseases of 
the blood, dysentery and diarrhea1. Pharmacological 
studies of the plant revealed that the methanolic extract 
of stem bark of Bauhinia Racemosa (MEBR) shows 
analgesic, antipyretic, anti-inflammatory2, antimicrobial3, 
antioxidant, hepatoprotective4, and antitumor activity5. 
Chemical evaluation of the stem bark of Bauhinia Racemosa 
afforded 30-norhopane, ethyl cerotate, friedelin, palmitic 
acid, b-sitosterol, aplysterol, taraxeran-3a-ol, naringenin, 
kaempferol, quercetin, n-octacosane, b-sitosterol palmitate 
and docosanoic acid6. 
Many plants used in traditional medicine have 
immunomodulating activities, some of which stimulate both 
humoral and cell mediated immunity while others activate 
only the cellular components of the immune system, i.e. 
phagocytic function without affecting the humoral or cell 
mediated immunity. Some of these plants also suppress 
both humoral and cell mediated immunity7. During the 
functioning of the immune system, such as in phagocytosis, 
reactive oxygen species and nitrogen species are generated. 
If they are left unchecked they can affect the components of 
the immune system by inducing oxidative damage. This is 
more so in the elderly or during inflammation where there 
is excess generation of these reactive species than can be 
taken care of by defenses in the form of antioxidants. There 
are some indications of possible benefits of antioxidant 
supplementation. Natural compounds from medicinal 
plants having antioxidant have potential as therapeutic 
agents in this regard. Indian medicinal plants with the 
activities of antioxidant and immunomodulator have been 
identified; the few gargling examples are Allium sativum, 
Azadirachta indica, Emblica officinalis, Withania somnifera. 
Hence immunomodulation can go hand in hand with 
antioxidant8. Recent reports indicate that several types 
of flavonols stimulate human peripheral blood leukocyte 
proliferation. They significantly increase the activity of 
helper T-cell, cytokines, Interleukin 2, g-interferon, and 
macrophages and are thereby useful in the treatment of 
several diseases caused by immune dysfunction9. MEBR 
shows the presence of flavonoids, triterpenoids, steroids, 
tannins, and saponins4, the class of compounds which are 
known to have immunostimulant properties.  In the present 
study methanolic extract of stem bark of Bauhinia Racemosa 
(MEBR) was studied for its potential immunomodulatorty 
activity, driven by the presence of its antioxidant property 
and presence of class of compounds which are known to 
posses the immunostimulant properties.
MATERIAL AND METhODS
Plant material
The stem bark of Bauhinia Racemosa Lam. was collected 
from Solapur, Maharashtra, India. The plant specimen was 
authenticated by “Botanical Survey of India” Pune, India, 
(voucher specimen no.Sasp1)
Preparation of methanolic extract of stem barks of 
Bauhinia Racemosa Lam
The stem bark of Bauhinia Racemosa Lam. was dried in 
the shade and pulverized. The dried powder material of 
the stem bark of Bauhinia Racemosa was extracted with 
methanol (95%) by cold maceration (yield 9.25 %w/w). 
Experimental animal
All experimental procedures were carried out in strict 
accordance with the guidelines prescribed by the 
Committee for the Purpose of Control and Supervision 
on Experimentation on Animals (CPCSEA) and were 
approved by the  Institutional Animal Ethics Committee.
Swiss albino mice weighing between 18 to 25 gm of 
either sex were used. The above animals of either sex 
were purchased from National Toxicology Center, Pune. 
Animals had free access to standard pellet diet and water 
ad libitum. Fresh animals were used for each experiment.
Drugs and chemicals
Cyclophosphamide 100 mg/kg was used as a standard 
immunosuppressant.
Carbon ink suspension: Pelican AG,Germany,ink was 
diluted eight times with saline and used for carbon 
clearance test in a dose of 10µl/gm body weight of mice.
Sheep red blood cells (SRBCs) were washed three times with 
normal saline and adjusted to the required concentration 
for immunization and for challenge as antigen.
humoral antibody response10-12
Animals were divided into 8 groups of six animals each. 
Animals in group I received orally 1ml of 5% gum acacia, 
for 21 days. Group II received cyclophosphamide 100mg/
kg, p.o, on 9th and 16th day. Animals in group III, IV and V 
with normal immune status were administered MEBR at 
doses of 50, 100, 200 mg/kg/day, p.o, respectively for 21 
days. Animals in group VI, VII and VIII received MEBR at 
doses of 50, 100, 200 mg/kg, p.o, respectively for 21 days 
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3in addition to cyclophosphamide 100 mg/kg, p.o, on day 
9th and 16th . On 7th and 14th day of the study, mice from all 
the groups were immunized and challenged respectively, 
with 0.1 ml of 20% sheep red blood cell’s (SRBC) in normal 
saline intraperitoneally. Blood was withdrawn on 14th 
and 21st day from retro-orbital plexus under mild ether 
anesthesia from all animals and centrifuged to obtain 
serum. The antibody titer was determined using microtiter 
plates. Each well of a microtiter plate was filled initially 
with 25 µl of normal saline, 25 µl of serum was mixed 
with 25 µl of normal saline in the first well of microtiter 
plate. Twofold dilutions of serum were made till the last 
well of the second row of microtiter plate, so that the 
antibody concentration of any of the dilutions is half of 
the previous dilution. 25 µl of 1% SRBC   were added to 
each well and the microtiter plates were incubated at 37°C 
for one hour and then observed for hemagglutination. The 
highest dilution giving hemagglutination was taken as the 
antibody titer. The antibody titers were expressed in the 
graded manner, the minimum dilution (1/2) being ranked 
as 1, and mean ranks of different groups were compared 
for statistical significance. Antibody titer obtained on 14th 
day after immunization and on 21st day after challenge 
with SRBCs was considered as primary and secondary 
humoral immune response respectively.  
Carbon Clearance Test13
Mice were divided into 4 groups of six animals each. The 
control group I received orally 1ml of 5% gum acacia, 
while animals of treatment group II, III, and IV were 
administered MEBR at doses of 50, 100, 200 mg/kg/day, 
p.o. respectively daily for 5 days. Carbon ink suspension 
10µl/gm body weight of mice was injected via tail vein to 
each mouse 48hrs after the 5 day treatment. Blood samples 
(25 µl) were then withdrawn from retro orbital plexus 
under mild ether anesthesia at 0 and 15 minutes after 
injection of colloidal carbon ink and lysed in 0.1% sodium 
carbonate solution (3ml). The optical density was measured 
spectrophotometrically at 660 nm. The phagocytic index 
was calculated using the following formula
samples from all the groups were collected by puncturing 
retro-orbital plexus under mild ether anaesthesia. 
Blood was collected in vials pre-treated with  disodium 
EDTA and analysed for total leukocyte count (TLC) and 
differential leukocyte count (DLC) by fixing blood smears 
and staining with Field stain I and Leishman’s stain. After 
initial counts, blood samples were incubated with nylon 
fiber (80 mg/ml of blood sample) for 15 min at 370C. The 
incubated blood samples were again analyzed for TLC and 
DLC. The product of TLC and percentage neutrophil gives 
neutrophil index (NI) of blood sample. Percent neutrophil 
adhesion was calculated as follows. 
(In OD1 – In OD2)
(t2 – t1)
K =
Where OD1 and OD2 are the optical densities at time t1 and 
t2 respectively
Neutrophil Adhesion Test14
Mice were divided into 4 groups of six animals each. The 
control group I recived orally 1ml  of 5% gum acacia, while 
animals of treatment groups II, III and IV were administered 
MEBR at doses of 50, 100, 200 mg/kg/day, p.o.respectively 
daily for 7 days. On the 7th day of the treatment, blood 
Where,
NIu:Neutrophil Index before incubation with nylon fibers.
NIt  :Neutrophil Index after incubation with nylon fibers.
Statistical analysis
The results are expressed as mean ± S.E.M. Data was 
analyzed by one-way ANOVA followed by Tukey-Kramar 
multiple comparison test. Value of p less than 5% (i.e. 
p<0.05) was considered statistically significant.
RESULTS
humoral Antibody Response
Primary antibody response on day 14th in MEBR treated 
group with normal immune status showed no significant 
rise in H.A.Titer when compared with control group. A 
significant decrease in H.A.Titer (p<0.01) was observed 
in cyclophosphamide treated group when compared 
with control group. In immunosuppresed group where 
the immunity was suppressed by administration of 
cyclophosphamide on day 9th ,  MEBR administration 
produced a significant  rise in H.A.Titer (p<0.01) at dose 
of  200 mg/kg when compared with cyclophosphamide 
treated group. Secondary antibody response on day 21st day 
in MEBR treated groups  with normal immune status group 
showed no significant rise in H.A.Titer when compared 
with control group.  A significant decrease in H.A.Titer 
(p<0.001) was seen in cyclophosphamide group II when 
compared with control group I. In immunosuppresed group 
where the immunity was suppressed by administration of 
cyclophosphamide on day 16th, MEBR showed Significant 
rise in H.A.Titer (p<0.01) at dose 200 mg/kg respectively 
when compared with cyclophosphamide group (Table 1).
Carbon Clearance Test
The phagocytic activity of reticuloendothelial system 
is generally measured by the rate of removal of carbon 
NIu-NIt
NIu
Neutrophil adhesion =                     x 100
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4Table 1.  Effect of methanolic extract of stem bark of Bauhinia racemosa on primary and secondary antibody 
response on h.A.titer. 
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particles from blood stream, there was significant increase 
in phagocytic activity (p<0.05) of MEBR at dose of 200 mg/
kg when compared with control (Table 2), indicating that 
MEBR posses macrophage stimulatory activity. 
Neutrophil Adhesion Test
MEBR increased the adhesion of neutrophil to nylon 
fibres which co-relates to the process of margination of 
neutrophils in blood vessels. The neutrophil adhesion was 
Group nº Group
h.A.Titer
Primary Secondary
I Control 4.66 ± 0.33 7.5 ± 0.22
II Cyp 3.00 ± 0.25** a 5.5 ± 0.22*** a
III MEBR 5.33 ± 0.21 7.66 ± 0.42
IV MEBR 5.66 ± 0.33 8.16 ± 0.16
V MEBR 5.83 ± 0.30 8.50 ± 0.22
VI MEBR +  Cyp 3.16 ± 0.40 6.0 ± 0.25
VII MEBR  + Cyp 4.33 ± 0.21 6.83 ± 0.30
VIII MEBR  + Cyp 4.66 ± 0.21** b 7.66 ± 0.55 ** b
MEBR: Methanolic extract of stem bark of Bauhinia Racemosa; Cyp: Cyclophosphamide; Values are expressed as (Mean± S.E.M), n=6, **p<0.01 and 
***p<0.001; a:  when compared with control (Group I); b: when compared with Cyclophosphamide Control (Group II); (Statistically analyzed by one 
way ANOVA followed by Tukey-Kramar multiple Comparison test.)
Table 2. Effect of methanolic extract of stem bark of Bauhinia racemosa on phagocytic activity by carbon clearance 
test. 
MEBR: Methanolic extract of stem bark of Bauhinia Racemosa; Values are expressed as (Mean± S.E.M), n=6; * = p<0.05 ; MEBR treated groups were 
compared with control. (Statistically analyzed by one way ANOVA followed by Tukey-Kramar multiple Comparison test.)
Group nº Group Phagocytic index
I Control 0.011 ± 0.00096
II MEBR 0.011 ± 0.00073
III MEBR 0.012 ± 0.00061
IV MEBR 0.018 ± 0.00088 *
Table 3. Effect of methanolic extract of stem bark of Bauhinia racemosa on neutrophil activation by neutrophil 
adhesion test.
MEBR: Methanolic extract of stem bark of Bauhinia Racemosa; Values are expressed as (Mean± S.E.M), n=6; ** = p<0.01; MEBR treated groups were 
compared with control.(Statistically analyzed by one way ANOVA followed by Tukey-Kramar multiple Comparison test.)
Group nº Group % Neutrophil Adhesion
I Control 30.77 ± 1.26
II MEBR 30.89 ± 1.43
III MEBR 32.07 ± 1.33
IV MEBR 39.25 ± 2.15 **
significantly increased (p<0.01) with MEBR at dose of 200 
mg/kg when compared with control (Table 3).
DISCUSSION
Immunomodulatory agents of plants and animal origin 
enhance the immune responsiveness of an organism 
against a pathogen by activating the immune system15. 
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Antioxidant supplementation essentially reverses several 
immune deficiences, resulting in increased levels of 
interleukin-2, elevated numbers of total lymohocytes and 
T-cell subsets, enhanced mitogen responsivness, increased 
killer cell activity, augmented antibody response to antigen 
stimulation, decreased lipid peroxidation, and decreased 
prostaglandin synthesis16.
         When mice are sensitized with SRBC, an antigen gets 
diffused in the extra vascular space and enters the lymph 
node via the lymphatics. B cells with receptors for antigen 
bind and internalize it into an endosomal compartment 
and process and presents it on MHC class II molecules to 
TH2 cells. These B cells are triggered to proliferate, giving 
rise to clones of large numbers of daughter cells. Some of 
the cells of these expanding clones serve as memory cells, 
other differentiates and become plasma cells that make 
and secrete large quantities of specific antibody. During a 
primary response, IgM is secreted initially, often followed 
by a switch to an increasing proportion of IgG17, 18. The 
magnitude of secondary antibody response to the same 
antigen is amplified in terms of antibody production. In 
present study assesment of humoral immunity was carried 
out using H.A.Titer .The anti-SRBC antibody titer in MEBR 
treated group was raised but was not found statistically 
significant when compared to control group in both 
primary and secondary antibody titer response.
          In the immunosuppressed groups cyclophosphamide 
was used as immunosuppressant as, it selectively 
suppresses humoral immunity by exerting depressive 
effect on antibody production, if given after antigenic 
stimulation19. This may be due to interference with helper 
T cell activity20. MEBR 200 mg/kg significantly protected 
cyclophosphamide induced suppression of humoral 
immunity, probably by counteracting suppression of both 
primary and secondary humoral response.          
The increase in carbon clearance index reflects the 
enhancement of phagocytic function of mononuclear 
macrophage and non–specific immunity. MEBR 
significantly increased the phagocytic activity when 
compared to control.
MEBR significantly evoked increase in adhesion of 
neutrophils to nylon fibre which co-relate to the process 
of margination of cells in blood vessels. The neutrophil 
adhesion was significantly increased by MEBR when 
compared to control. 
 The present investigation therefore reveals that 
stem bark of Bauhinia Racemosa Lam certainly possess 
immunomodulatory properties.
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